rb 88716 has been researched along with lomustine in 1 studies
*Lomustine: An alkylating agent of value against both hematologic malignancies and solid tumors. [MeSH]
*Lomustine: An alkylating agent of value against both hematologic malignancies and solid tumors. [MeSH]
Studies (rb 88716) | Trials (rb 88716) | Recent Studies (post-2010) (rb 88716) | Studies (lomustine) | Trials (lomustine) | Recent Studies (post-2010) (lomustine) |
---|---|---|---|---|---|
6 | 0 | 0 | 1,975 | 492 | 274 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Siemann, DW; Sutherland, RM | 1 |
1 other study(ies) available for rb 88716 and lomustine
Article | Year |
---|---|
Potentiation of alkylating chemotherapy by dual function nitrofurans in multi-cell spheroids and solid tumors.
Topics: Animals; Antineoplastic Agents; Aziridines; Bone Marrow; Carcinoma; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Lomustine; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Misonidazole; Nitrofurans; Radiation-Sensitizing Agents; Sarcoma, Experimental; Stem Cells; Tumor Cells, Cultured | 1992 |